retatrutide clinical trial parkinson Reta data & dosing โ a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health โ targeting GLP-1, GIP, ๐๐ฅ๐ฒ๐๐ฎ๐๐ฟ๐๐๐ถ๐ฑ๐ฒ'๐ ๐จ๐ป๐ฒ๐ ๐ฝ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐ฆ๐ถ๐ฑ๐ฒ ๐๐ณ๐ณ๐ฒ๐ฐ๐: ๐ช๐ต๐ฎ๐
Description
Here's what we learned about midlife GLP-1 use in 2025.
2ml per day, can be used for 60 days, can be dripped directly into the mouth, enjoy the fresh raspberry flavor
100 mg de t verde (95% polifenoles, 80% catequinas, 50% EGCG y 1% cafena)
Not an actual retatrutide product image.)
